What does Arcutis Biotherapeutics, Inc. do?
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic…
What is Arcutis Biotherapeutics, Inc.'s P/E and P/B ratio?
Arcutis Biotherapeutics, Inc. has a P/E ratio of 146.4 and a P/B ratio of 18.35.
What is Arcutis Biotherapeutics, Inc.'s debt-to-equity ratio?
Arcutis Biotherapeutics, Inc. has a debt-to-equity ratio of 0.52.
How much does Arcutis Biotherapeutics, Inc. owe compared with what it owns?
Arcutis Biotherapeutics, Inc. owes $0.55 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Arcutis Biotherapeutics, Inc.'s Positivity rank?
Arcutis Biotherapeutics, Inc. is ranked #6,041 of 6,775 companies globally and #3,413 of 4,000 in United States on PositoAI, with a Positivity Score of 11,398.
Does Arcutis Biotherapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Arcutis Biotherapeutics, Inc..
Where can I read the latest news about Arcutis Biotherapeutics, Inc.?
Recent headlines about Arcutis Biotherapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Arcutis Biotherapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Arcutis Biotherapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.